Monteith C, et al. – Analysts firstly recognize the different haemodynamic profiles amongst nulliparous women who develop either gestational hypertension (GH), pre–eclampsia (PE), normotensive fetal growth restriction (FGR) versus unaffected pregnancies using non–invasive cardiac output monitoring (NICOM®) and aim to evaluate the ability of NICOM® derived variables to predict the assessment of PE, GH and FGR. NICOM® derived maternal haemodynamic profile at 14 weeks' gestation has the novel potential to recognize pregnancies which will ultimately develop uteroplacental disease.